文献速递脑血管病

德国移动卒中单元服务的经济学评价

Economic Evaluation of a Mobile Stroke Unit Service in Germany.
PubMed 文献 · Ann Neurol · 2023-01-27

本研究基于前瞻性对照干预研究B_PROUD的数据,评估额外派遣移动卒中单元(MSU)的成本效用与成本效果。结果显示,MSU派遣每增加一个QALY的成本为40984欧元,每增加一例无残疾生存的成本为81491欧元;在考虑国际公认的每QALY额外40000至80000欧元阈值时,MSU派遣具有成本效果。

要点

  • 在符合再通治疗的缺血性卒中患者中,额外MSU派遣与更高QALY和更高成本相关。
  • MSU派遣每QALY增量成本为40984欧元,最佳和最差情景分别为24470.76和61690.88欧元。
  • MSU派遣每无残疾生存增量成本为81491欧元,最佳和最差情景分别为44455.30和116491.15欧元。

核心结论

  • 在符合再通治疗的缺血性卒中患者中,MSU派遣与更高QALY和更高成本相关,在考虑国际公认的每QALY额外40000至80000欧元阈值时具有成本效果。

研究设计与样本

  • 基于前瞻性对照干预研究B_PROUD的数据,评估额外派遣MSU的成本效用和成本效果,结果聚焦社会视角,成本和QALY外推至5年。

主要发现

  • 额外MSU派遣每QALY增量成本为40984欧元,最佳情景为24470.76欧元,最差情景为61690.88欧元。
  • 在成本效果分析中,MSU派遣每无残疾生存增量成本为81491欧元,最佳情景为44455.30欧元,最差情景为116491.15欧元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lower global disability and higher quality of life among ischemic stroke patients was found to be associated with the dispatch of mobile stroke units (MSUs) among patients eligible for recanalizing treatments in the Berlin_Prehospital Or Usual Delivery of stroke care (B_PROUD) study. The current study assessed the cost-utility and cost-effectiveness of additional MSU dispatch using data from this prospective, controlled, intervention study. METHODS: Outcomes considered in the economic evaluation included quality-adjusted life years (QALYs) derived from the 3-level version of EQ-5D (EQ-5D-3L) and modified Rankin Scale (mRS) scores for functional outcomes 3-months after stroke. Costs were prospectively collected during the study by the MSU provider (Berlin Fire Brigade) and the B_PROUD research team. We focus our results on the societal perspective. As we aimed to determine the economic consequences of the intervention beyond the study's follow-up period, both care costs and QALYs were extrapolated over 5 years. RESULTS: The additional MSU dispatch resulted in an incremental €40,984 per QALY. The best-case scenario and the worst-case scenario yielded additional costs of, respectively, €24,470.76 and €61,690.88 per QALY. In the cost-effectiveness analysis, MSU dispatch resulted in incremental costs of €81,491 per survival without disability. The best-case scenario and the worst-case scenario yielded additional costs of, respectively, €44,455.30 and €116,491.15 per survival without disability. INTERPRETATION: Among patients eligible for recanalizing treatments in ischemic stroke, MSU dispatch was associated with both higher QALYs and higher costs and is cost-effective when considering internationally accepted thresholds ranging from an additional €40,000 to €80,000 per QALY. ANN NEUROL 2023;93:942-951.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Oliveira Gonçalves AS, Rohmann JL, Piccininni M, et al. Economic Evaluation of a Mobile Stroke Unit Service in Germany. Ann Neurol. 2023. PMID: 36637359. doi:10.1002/ana.26602

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。